350 related articles for article (PubMed ID: 27676420)
1. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder.
Detke HC; DelBello MP; Landry J; Hoffmann VP; Heinloth A; Dittmann RW
J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):922-934. PubMed ID: 27676420
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine: in adolescents with schizophrenia or bipolar I disorder.
McCormack PL
CNS Drugs; 2010 May; 24(5):443-52. PubMed ID: 20369908
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
[TBL] [Abstract][Full Text] [Related]
5. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
8. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mostafavi SA; Solhi M; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):440-444. PubMed ID: 28339282
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
Detke HC; DelBello MP; Landry J; Usher RW
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
[TBL] [Abstract][Full Text] [Related]
10. Weight gain during treatment of bipolar I patients with olanzapine.
Hennen J; Perlis RH; Sachs G; Tohen M; Baldessarini RJ
J Clin Psychiatry; 2004 Dec; 65(12):1679-87. PubMed ID: 15641874
[TBL] [Abstract][Full Text] [Related]
11. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
[TBL] [Abstract][Full Text] [Related]
12. The safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials.
Kryzhanovskaya LA; Robertson-Plouch CK; Xu W; Carlson JL; Merida KM; Dittmann RW
J Clin Psychiatry; 2009 Feb; 70(2):247-58. PubMed ID: 19210948
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
Tohen M; Vieta E; Goodwin GM; Sun B; Amsterdam JD; Banov M; Shekhar A; Aaronson ST; Bardenstein L; Grecu-Gabos I; Tochilov V; Prelipceanu D; Oliff HS; Kryzhanovskaya L; Bowden C
J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
Katagiri H; Tohen M; McDonnell DP; Fujikoshi S; Case M; Kanba S; Takahashi M; Gomez JC
BMC Psychiatry; 2013 May; 13():138. PubMed ID: 23672672
[TBL] [Abstract][Full Text] [Related]
17. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.
Kemp DE; Correll CU; Tohen M; Delbello MP; Ganocy SJ; Findling RL; Chang K
J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):522-30. PubMed ID: 24111982
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
Lee HB; Yoon BH; Kwon YJ; Woo YS; Lee JG; Kim MD; Bahk WM
Clin Drug Investig; 2013 Oct; 33(10):743-53. PubMed ID: 23990283
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
[TBL] [Abstract][Full Text] [Related]
20. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]